Vascular endothelial growth factor A as a marker of bevacizumab in glioblastoma

被引：0
|
作者：
You, Weir Chiang
Lin, Jin-Ching
机构：
[1] Taichung Vet Gen Hosp, Dept Radiat Oncol, Taichung, Taiwan
[2] Taichung Vet Gen Hosp, Taichung, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e14068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14068
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Lessons From Anti-Vascular Endothelial Growth Factor and Anti-Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma
    Lu-Emerson, Christine
    Duda, Dan G.
    Emblem, Kyrre E.
    Taylor, Jennie W.
    Gerstner, Elizabeth R.
    Loeffler, Jay S.
    Batchelor, Tracy T.
    Jain, Rakesh K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (10) : 1197 - 1213
  • [22] Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
    Toshihiro Nagai
    Masato Sato
    Miyuki Kobayashi
    Munetaka Yokoyama
    Yoshiki Tani
    Joji Mochida
    Arthritis Research & Therapy, 16
  • [23] Anti-vascular endothelial growth factor bevacizumab (Avastin) for radiation retinopathy
    Finger, Paul T.
    Chin, Kimberly
    ARCHIVES OF OPHTHALMOLOGY, 2007, 125 (06) : 751 - 756
  • [24] Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab
    Sawada, Osamu
    Kawamura, Hajime
    Kakinoki, Masashi
    Ohji, Masahito
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 246 (10) : 1379 - 1381
  • [25] Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
    Nagai, Toshihiro
    Sato, Masato
    Kobayashi, Miyuki
    Yokoyama, Munetaka
    Tani, Yoshiki
    Mochida, Joji
    ARTHRITIS RESEARCH & THERAPY, 2014, 16 (05)
  • [26] HYPERTENSION IN PATIENTS TREATED WITH BEVACIZUMAB (MONOCLONAL ANTIBODY TO VASCULAR ENDOTHELIAL GROWTH FACTOR)
    Marina, I.
    Marcuello, E.
    Soler, M. J.
    Roca-Cusach, A.
    JOURNAL OF HYPERTENSION, 2009, 27 : S434 - S434
  • [27] Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab
    Osamu Sawada
    Hajime Kawamura
    Masashi Kakinoki
    Masahito Ohji
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2008, 246 : 1379 - 1381
  • [28] Effects of Intravitreally Injected Bevacizumab on Vascular Endothelial Growth Factor in Fellow Eyes
    Matsuyama, Kayako
    Ogata, Nahoko
    Matsuoka, Masato
    Wada, Mitsumasa
    Nishimura, Tetsuya
    Takahashi, Kanji
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 27 (04) : 379 - 383
  • [29] Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation
    Tatar, O.
    Shinoda, K.
    Kaiserling, E.
    Claes, C.
    Eckardt, C.
    Eckert, T.
    Pertile, G.
    Boeyden, V.
    Scharioth, G. B.
    Yoeruek, E.
    Szurman, P.
    Bartz-Schmidt, K. U.
    Grisanti, S.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (02) : 159 - 165
  • [30] Urine vascular endothelial growth factor-A is not a useful marker for endometriosis
    Potlog-Nahari, C
    Stratton, P
    Winkel, C
    Widra, E
    Sinaii, N
    Connors, S
    Nieman, LK
    FERTILITY AND STERILITY, 2004, 81 (06) : 1507 - 1512
12345